Pfizer sues departing employee it says stole COVID-19 vaccine secrets

  • In US
  • 2021-11-24 21:20:53Z
  • By Reuters

By Jonathan Stempel

(Reuters) - Pfizer Inc has sued a longtime employee for allegedly stealing "scores" of confidential documents, including some related to its COVID-19 vaccine, as she prepared to jump to a competitor.

In a complaint filed on Tuesday in San Diego federal court, Pfizer said Chun Xiao Li breached her confidentiality agreement by uploading more than 12,000 files without permission to her personal accounts and devices from her company-issued laptop.

The alleged materials include a Sept. 24 "playbook" containing internal assessments and recommendations about the Pfizer/BioNTech COVID-19 vaccine, Pfizer's relationship with its German vaccine partner, and presentations related to cancer antibodies.

Pfizer said Li, an associate director of statistics, tried repeatedly to cover her tracks, even providing a "decoy" laptop to fool it into thinking what she did with the files.

Li "has misled Pfizer about what she took, how she took it, when and why she did it, and where those files (and possibly others) can be found," the New York-based drugmaker said.

Pfizer said Li is resigning after 15 years at the company, and appears to have an offer to join Xencor Inc, a California clinical-stage company focusing on treatments for cancer and autoimmune diseases, on Nov. 29.

Li could not immediately be reached for comment through her LinkedIn account. Xencor is not a defendant in the lawsuit, and declined to comment.

Pfizer said competitors have been trying to recruit its employees "relentlessly, especially during 2021."

In an order late on Tuesday, U.S. District Judge Cathy Ann Bencivengo temporarily blocked Li from using Pfizer's trade secrets, and said the company's lawyers can review accounts and devices where she might have stored them.

The judge scheduled a Dec. 9 hearing to consider a longer injunction.

(Reporting by Jonathan Stempel in New York; Additional reporting by Nate Raymond in Boston; Editing by Leslie Adler)


More Related News

South Africa
South Africa's Aspen in advanced talks over COVID-19 vaccine deal
  • US
  • 2021-11-29 15:47:09Z

Aspen Pharmacare is in advanced discussions over a potential licensing agreement to package the COVID-19 vaccine in South Africa, it said on Monday. Aspen...

UK vaccine advisers say all adults to receive boosters
UK vaccine advisers say all adults to receive boosters
  • US
  • 2021-11-29 15:13:32Z

Britain will offer a COVID-19 booster vaccine to all adults and give second doses to children aged between 12 and 15, the UK's top vaccine advisers said on...

Pfizer now expects to produce 80 million courses of COVID-19 pill, CEO tells CNBC
Pfizer now expects to produce 80 million courses of COVID-19 pill, CEO tells CNBC
  • US
  • 2021-11-29 13:26:51Z

Earlier this month, Pfizer said it expects to manufacture 180,000 treatment courses by the end of this year and at least 50 million courses by the end of...

BioNTech starts work on Omicron-specific vaccine
BioNTech starts work on Omicron-specific vaccine
  • US
  • 2021-11-29 12:49:14Z

BioNTech SE said on Monday it had started work on a vaccine tailored to Omicron, the worrying new coronavirus variant

Philippines to buy extra 20 million doses of Pfizer
Philippines to buy extra 20 million doses of Pfizer's COVID-19 vaccine

The Philippines will buy an additional 20 million doses of the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, seeking to fully inoculate more than...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: US